MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Sales and maturitiesof investments$35,000K Net parentinvestment-$7,851K Net cash provided byinvesting activities$34,983K Net cash provided byfinancing activities$7,851K Canceled cashflow$17K Net increase(decrease) in cash and cash...$10,273K Canceled cashflow$32,561K Purchases of property andequipment$17K Stock-based compensation$11,503K Accounts payable andother liabilities$4,146K Prepaid expenses andother assets-$2,157K Depreciation andamortization$125K Net cash used inoperating activities-$32,561K Canceled cashflow$17,931K Net loss-$50,484K Accretion/amortization of investments,net$8K
Cash Flow

First Tracks Biotherapeutics, Inc. (TRAX)

First Tracks Biotherapeutics, Inc. (TRAX)

source: myfinsight.com